Pneumococcal Conjugate Vaccine Impact on Serotype 3: A Review of Surveillance Data

INTRODUCTION: Limited changes in serotype 3 invasive pneumococcal disease (IPD) incidence rates after a decade of 13-valent pneumococcal conjugate vaccine (PCV13) introduction into several national immunization programs (NIP) have raised questions about PCV13's effectiveness against this seroty...

Descripción completa

Detalles Bibliográficos
Autores principales: Sings, Heather L., Gessner, Bradford D., Wasserman, Matt D., Jodar, Luis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7954992/
https://www.ncbi.nlm.nih.gov/pubmed/33587245
http://dx.doi.org/10.1007/s40121-021-00406-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7954992/
https://www.ncbi.nlm.nih.gov/pubmed/33587245
http://dx.doi.org/10.1007/s40121-021-00406-w

Ejemplares similares